Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,330 JPY | -0.37% | +1.33% | +3.70% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- With a 2024 P/E ratio at 23.04 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
Ratings chart - Surperformance
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.70% | 1.17B | - | ||
-1.11% | 261B | B- | ||
+20.26% | 20.62B | B+ | ||
0.00% | 19.33B | - | - | |
+17.12% | 12.66B | A- | ||
-13.65% | 9.11B | A- | ||
+23.03% | 8.21B | B+ | ||
+11.07% | 6.12B | B | ||
-11.72% | 4.09B | B+ | ||
-17.24% | 3.81B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 4928 Stock
- Ratings Noevir Holdings Co., Ltd.